Intravenous magnesium sulphate in the management of refractory bronchospasm in a ventilated asthmatic

Anaesthesia

Volumn 52, Issue 8, 1997, Pages 783-785

  Mills, R ^a   Leadbeater, M ^b   Ravalia, A ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

^c KINGSTON HOSPITAL   (United Kingdom)

Author keywords

Complications; asthma; Lung; bronchus; Pharmacology; magnesium sulphate

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MAGNESIUM SULFATE; STEROID; THEOPHYLLINE;

ADULT; AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHOSPASM; CASE REPORT; DRUG EFFICACY; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; WEANING;

EID: 0030738904     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.176-az0312.x     Document Type: Article

References (15)

1. Rossello JC, Pla JC. Sulfato de magnesio en la crisis de asma. Prensa Medica Argentina 1936; 23: 1677-80.
2. Haury VG. Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulphate. Journal of Laboratory and Clinical Medicine 1940; 26: 340-1.
3. Sydow M, Crozier TA, Zielman S, Radke J, Burchardi H. High dose intravenous magnesium sulfate in the management of life threatening status asthmaticus. Intensive Care Medicine 1993; 19: 467-71.
4. Skobeloff EM, Spivey WH, Mcnamara RM, Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. Journal of the American Medical Association 1989; 262: 1210-13.
5. Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Bronchodilating effects of intravenous magnesium sulfate in bronchial asthma. Journal of the American Medical Association 1987; 257: 1076-8.
6. Noppen M, Vanmaele L, Impens N, Schandevyl W. Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 1990; 97: 373-6.
7. Sharma SK, Bhargava A, Pande JN. Effect of parenteral magnesium sulfate on pulmonary functions in bronchial asthma. Journal of Asthma 1994; 31(2): 109-15.
8. Mcnamara RM, Spivey WH, Skobeloff EM, Jacubowitz S. Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. Annals of Emergency Medicine 1989; 18: 197-9.
9. Green SM, Rothrock SG. Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Annals of Emergency Medicine 1992; 21: 260-5.
10. Leff A. Pathophysiology of asthmatic bronchoconstriction. Chest 1982; 82: 135-215.
11. Altura BM, Altura BT. Magnesium withdrawal and contraction of arterial smooth muscle; effects of EDTA, EGTA, and divalent cations. Proceedings of the Society of Experimental Biological Medicine 1976; 151: 752-5.
12. Whyte KF, Addis GJ, Whitesmith R, Reid JL. Adrenergic control of plasma magnesium in man. Clinical Science 1987; 72: 135-8.
13. Delcastillo J, Engbaek L. The nature of the neuromuscular block produced by magnesium. Journal of Physiology 1954; 124: 370-84.
14. Wacker WEC, Vlee BL. Magnesium metabolism. New England Journal of Medicine 1958; 259: 431-8 and 452-82.
15. Molloy DW, Dhingra S, Solven S, Wilson A, Mccarthy DS. Hypomagnesemia and respiratory muscle power. American Review of Respiratory Disease 1984; 129: 497-8.